BAI Announces 2021 Global Innovation Award Finalists
9.11.2021 15:30:00 EET | Business Wire | Press release
BAI announced the finalists for the 11th Annual 2021 BAI Global Innovation Awards, the industry’s prestigious awards program that celebrates new and innovative solutions in the financial services industry worldwide. The 2021 BAI Global Innovation Awards finalists are:
Innovation in Compliance and Risk Management
- Emirates NBD Bank, United Arab Emirates: Transforming the Anti-Money Laundering Framework
- Hummingbird, United States: Hummingbird Platform
- UnionBank of the Philippines, Philippines: Credit Card Fraud Detection Model
Innovation in Consumer Product and Services
- Commonwealth Bank of Australia, Australia: CommBank Benefits Finder
- FNB Insurance, South Africa: Future Family Benefit on Critical Illness
- ICICI Bank, India: IntelliCollect – AI powered Contactless Collection
- PNC Financial Services Group, United States: Low Cash Mode
- Yapı Kredi, Turkey: My Car+: Everything about your vehicle
Innovation in Digital Transformation
- AVIVA POLSKA, Poland: eInsurance Digital Omnichannel Life Insurance Application Journey
- Bank of America, United States: Bank of America Mobile Banking Super App
- Deutsche Bank, Germany: Deutsche Bank API Program Embedded Finance Initiative
- OneConnect Smart Technology Co., LTD, China: Global Markets Digital Lab in Abu Dhabi
- SolarisBank, Netherlands: Banking as a Service
Innovation in Human Capital
- KeyBank, United States: Remote Intern Program
- Payactiv, United States: Livelihood Employee Experience Platform
- Royal Credit Union, United States: Employee Learning Experience
Innovation in Environmental, Social and Governance (ESG)
- Bank of Montreal, Canada: BMO Give & Go
- BMO Harris Bank, United States: BMO for Black and Latinx Businesses
- Citizens Financial Group, United States: Citizens Green Deposits
- imagin, Spain: imagin: A Community with a Positive Impact
- Lufax Holding Ltd., China: Farmers’ Assistance Fund
- Wintrust Financial Corporation, United States: Wintrust Paycheck Protection Program (PPP) Resource Centers
Innovation in Internal Process
- Alior Bank, Poland: InfoNina, virtual assistant
- ICICI Bank, India: Pre-Delinquency Management
- Israel Discount Bank, Israel: POPCORN - An Innovative Customer Listening Model
- PKO Bank Polski, Poland: Road to Paperless Banking Empowered by Blockchain Technology
- PZU SA, South Africa: AI Assistant in Claims (Field Inspection)
Innovation in Small Business Product & Services
- HSBC UK, United Kingdom: HSBC Kinetic, Mobile Banking Service
- Lufax Holding Ltd., China: Lufax "Xingyun" Smart Loan Solution
- Ping An OneConnect Bank Limited, Hong Kong: “PAOB SME" Mobile Application
- Santander Bank, N.A., United States: Santander Treasury Fusion for Where You Do Business
- Tribal Credit, United States: Tribal Credit Tools
The winners will be announced in December 2021. To learn more please visit BAI Global Innovation Awards.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005488/en/
Contact information
Holly Hughes
BAI, Chicago
hhughes@bai.org
+1 (312) 683-2305
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 18:08:00 EEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubrutinib) plus next-generation BCL2 inhibitor BEQALZI™ (sonrotoclax; ZS), which continue to demonstrate rapid, deep, durable responses across multiple B-cell malignancies. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “BTK inhibition has reshaped the treatment of B-cell cancers, and we believe degradation is the next leap forwa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom